Intas pharma gets CDSCO panel nod to manufacture, market schizophrenia drug Clozapine Susmita Roy21 Feb 2022 5:00 PM ISTNew Delhi: Pharmaceutical major Intas Pharmaceuticals has got a green signal from the Subject Expert Committee (SEC) functional under the Central...
Intas Pharma unveils antifungal drug SB-100mg Itraconazole Roshni Dhar21 Oct 2021 4:40 PM ISTIn a progressive breakthrough in the Antifungal Therapy domain, Intas Pharmaceuticals has launched the world's first Super Bioavailable...
First: Intas Pharma launches antifungal drug SB-100mg Itraconazole Ruchika Sharma18 Oct 2021 11:45 AM ISTPatients can take Itaspor SB Forte/ Subawin with or without a meal with just water or as directed by the physician.
FIRST: Intas Pharma launches Oral Azacitidine under brand name Azadine-O Ruchika Sharma26 Sept 2021 10:15 AM ISTAhmedabad: In a significant development, drugmaker Intas Pharma has announced the launch of Oral Azacitidine in India under the brand name of...
Intas Pharma, Meiji, Dong-A ST ink licensing agreement for biosimilar to Ustekinumab Ruchika Sharma24 July 2021 9:00 AM ISTAhmedabad: Intas Pharmaceuticals Ltd has announced that the company has entered into an exclusive license agreement with Meiji and Dong-A Socio...
NPPA panel fixes price of Intas Pharma oncology drug, Details Medical Dialogues Team27 Jun 2021 10:15 AM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) Committee has suggested the retail price of an oncology drug combination pack of...
Indian Pharma sees robust growth of 51.5 percent in April sales: AIOCD-AWACS Report Medical Dialogues Team14 May 2021 11:00 AM ISTNew Delhi: The performance of the Indian Pharmaceutical Market (IPM) in April has portrayed a positive outlook for the Indian pharmaceutical industry...
All Escitalopram formulations to carry boxed warning: CDSCO tells 102 pharma firms Farhat Nasim5 Feb 2021 3:28 PM ISTNew Delhi: Through a recent notification, the Central Drugs Standard Control Organization (CDSCO) has directed all the manufacturers of Escitalopram...
NPPA to issue show-cause notice to Intas, Mankind Pharma for selling diabetes drug sans approval MD Bureau2 Jan 2021 4:56 PM ISTNew Delhi: Coming down on Mankind Pharma and Intas Pharmaceuticals, the National Pharmaceutical Pricing Authority (NPPA) has decided to issue...
Intas Pharma launches immuno booster add on drug to standard Covid treatment Ruchika Sharma12 Nov 2020 11:15 AM ISTThymoquinone has been developed as a stable, standardized and ready-to-use tablet by Intas for the first time in the world.
Intas Pharma COVID-19 specific Hyperimmune Globulin gets DCGI nod to conduct clinical trial Ruchika Sharma30 Aug 2020 10:30 AM ISTIntas is among the world's first to adopt this approach for treating COVID-19 patients. This will be a Corporate Social Responsibility (CSR)...
NPPA fixes retail prices of 30 formulations, defers Sun Pharma, Micro Labs new drug applications Farhat Nasim23 Aug 2020 12:43 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India has fixed prices of 30...
